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Histologically  adenocarcinomas  represent  95  %  of  all  gallbladder  carcinomas  [1].
Conversely,  primary  neuroendocrine  tumors  of  the  gallbladder  are  extremely  rare,  repre-
senting  0.2  %  of  all  neuroendocrine  tumors  and  only  2  %  of  all  gallbladder  carcinomas  [2].
The  diagnosis  of  primary  neuroendocrine  tumors  of  the  gallbladder  is  usually  made  during
histopathological  analysis  because  no  suggestive  imaging  features  that  allow  discriminat-
ing  between  this  speciﬁc  tumor  and  the  more  common  gallbladder  adenocarcinoma  have
been  described  [3].  Because  of  its  rarity,  the  imaging  features  of  primary  neuroendocrine
tumor  of  the  gallbladder  have  received  little  attention  so  far.We  report  herein  the  ultrasonographic  and  multidetector  row  computed  tomography
(MDCT)  ﬁndings  of  two  cases  of  histopathologically  conﬁrmed  primary  neuroendocrine
tumors  of  the  gallbladder  that  presented  as  large  gallbladder  masses  in  association  with
large  metastatic  lymph  nodes  and  intrahepatic  metastases.
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ase 1
 55-year-old  man  was  referred  to  us  because  of  non-speciﬁc
bdominal  pain.  He  also  complained  of  weight  loss.  He  had
o  remarkable  prior  history.  Physical  examination  showed
ild  jaundice  and  a  palpable  mass  in  the  right  upper  quad-
ant  of  the  abdomen.
Laboratory  tests  showed  low  serum  albumin  level
4.4  g/dL;  normal  value,  65—78)  and  elevated  aspar-
ate  aminotransferase  (AST)  (162  IU/L;  normal  value:
0—50),  alanine  aminotransferase  (ALT)  (189  IU/L;  nor-
al  value:  10—50),  alkaline  phosphatase  (255  IU/L;  normal
alue:  38—115),  total  bilirubin  (57.3  mol/dL;  normal
alue  <  17  mol/dL)  and  gamma  glutamyl  transpeptidase
1098  U/L;  normal  value  <  55)  levels.  Levels  of  tumor  mark-
rs  were  elevated  for  carbohydrate  antigen  (CA)  19—9
79.9  g/mL).
Ultrasonographic  examination  of  the  abdomen  revealed
he  presence  of  a  4-cm  mixed  echogenic  mass  in  segment  4
f  the  liver  and  an  8.5-cm  mass  in  the  fundus  of  the  gallblad-
er.  No  stones  were  visible  in  the  gallbladder  mass.  No  biliary
ilatation  was  noted  and  there  was  no  ascites.  MDCT  of  the
bdomen  showed  an  8.5  ×  6  cm  exophytic,  heterogeneous
ass  in  the  fundus  of  the  gallbladder  (Fig.  1).  There  were
wo  large  necrotic  lymphadenopathies  in  the  porta  hepatis
nd  retroportal  space.
The  patient  was  operated  on  and  intraoperative  explo-
ation  showed  a  large  gallbladder  mass  that  involved  the
egment  4  of  the  liver  and  a  large  lymph  node  of  the  porta
epatis.  The  tumor  was  found  to  involve  the  transverse
esocolon.  A  complex  surgical  resection  was  performed
onsisting  in  resection  of  segments  4,  5  and  6  and  right
olon.  The  patient  further  received  systemic  chemotherapy
onsisting  in  VP-16  and  cisplatin.
After  surgical  resection  histopathological  analysis
evealed  that  the  tumor  was  composed  of  monomorphic
ells  containing  small,  round  nuclei  and  eosinophilic  cyto-
lasm.  Cells  were  organized  in  small  nodular,  trabecular,
r  acinar  structures  surrounded  by  a  richly  vascularized
troma  in  association  with  multiple  mitoses.  Immunohis-
ochemical  analysis  revealed  that  the  cells  were  negative
or  cytokeratin,  vimentin,  and  CD-45  but  positive  for  CD
6,  chromogranin  A,  synaptophysin,  and  Ki  67  (90  %).  The
ame  ﬁndings  were  observed  on  resected  lymph  nodes  and
ntrahepatic  lesions.  These  ﬁndings  were  consistent  with
he  diagnosis  of  small  cell  neuroendocrine  carcinoma  of  the
allbladder  with  hepatic  and  lymph  node  involvement.  The
NM  classiﬁcation  of  the  tumor  was  T3  N1  M1.
ase 2
 64-year-old  woman  was  referred  to  us  because  of  abdom-
nal  pain  and  jaundice.  She  also  complained  of  anorexia
nd  a  weight  loss  of  5  kg  during  the  previous  month.  Her
rior  history  was  remarkable  for  type  2  diabetes,  inﬁltrative
reast  adenocarcinoma  treated  by  surgical  resection  and
on-alcoholic  steatohepatitis  (NASH).  Physical  examination
howed  mild  jaundice.  No  palpable  mass  of  the  abdomen
as  found.
Laboratory  tests  showed  elevated  AST  (134  U/L;  normal
alue:  10—50),  ALT  (126  IU/L;  normal  value;  10—50),  alkaline
r
o
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hosphatase  (350  IU/L;  normal  value  <  115),  total  biliru-
in  (235  mol/dL;  normal  value  <  17  mol/dL),  and  gamma
lutamyl  transpeptidase  (1098  U/L;  normal  value  <  55)  lev-
ls.  Levels  of  tumor  markers  were  elevated  for  CA  19—9
771  g/mL)  but  not  for  carcinoembryonic  antigen.
Ultrasonographic  examination  of  the  abdomen  revealed
he  presence  of  large,  heterogeneous  mass  measuring
5  ×  67  mm  that  appeared  to  originally  develop  from  the
allbladder  in  association  with  two  echogenic  masses  in
egment  4  of  the  liver  (Fig.  2).  Stone  was  visible  in  the
allbladder  mass.  Biliary  dilatation  in  the  left  hemiliver  was
resent.  MDCT  of  the  abdomen  conﬁrmed  presence  of  a  het-
rogeneous  mass  of  the  gallbladder  measuring  82  ×  65  mm  in
ssociation  with  two  hepatic  metastases  of  3-  and  4-cm  in
argest  axial  diameter  and  one  large  heterogeneous  necrotic
ymphadenopathy  in  the  porta  hepatis.
Percutaneous  biopsy  was  performed  and  histopathologi-
al  analysis  revealed  high  grade  neuroendocrine  carcinoma
f  the  gallbladder  with  hepatic  metastases.  Immunohis-
ochemical  analysis  revealed  that  the  tumor  cells  were
egative  for  cytokeratin,  vimentin  and  CD-45  but  positive
or  CD  56,  chromogranin  A,  synaptophysin  and  Ki  67  (100  %),
hus  excluding  liver  metastasis  from  breast  carcinoma.
The  patient  was  denied  surgery.  She  received  palliative
herapy  in  the  form  of  endoscopic  biliary  stent  placement
nd  chemotherapy  including  VP-16  and  cisplatin.  Follow-up
DCT  examination  revealed  complete  tumor  response  three
onths  later.
iscussion
apers  reporting  cases  of  primary  neuroendocrine  tumors
f  the  gallbladder  have  not  placed  a  special  attention  to
he  imaging  ﬁndings  of  this  speciﬁc  subgroup  of  gallbladder
umor.  In  some  reports,  the  tumor  itself  was  not  visible  at
maging  and  was  found  incidentally  during  histopathological
nalysis  of  resected  specimen  after  surgical  resection  of  the
allbladder  for  another  reason  that  the  tumor  itself  [4—6].  In
ther  cases,  the  tumor  presented  as  an  irregular,  circumfer-
ntial  thickening  of  the  gallbladder  [2]  or  as  an  intraluminal
olypoid  mass  [2,3,7]  similar  to  the  ﬁndings  observed  in  the
ore  common  adenocarcinoma  of  the  gallbladder  [6,8].  Pri-
ary  neuroendocrine  tumors  of  the  gallbladder  may  also
resent  as  chronic  cholecystitis  with  circumferential,  homo-
eneous  thickening  of  the  gallbladder  wall  with  intraluminal
tones  [9].  Finally,  primary  neuroendocrine  tumor  of  the
allbladder  may  present  as  a  large  gallbladder  mass,  which
s  also  a  ﬁnding  similar  to  the  more  common  gallbladder
denocarcinoma  as  observed  in  our  two  patients  [10].
The  most  frequent  MDCT  ﬁnding  in  gallbladder  adeno-
arcinoma  at  initial  presentation  is  a  mass  that  ﬁlls  more
f  50  %  of  an  enlarged  and  deformed  gallbladder  and  that
s  often  exophytic  [8,11].  The  mass  is  typically  hypoatten-
ating  and  shows  variable  degrees  of  enhancement.  The
econd  most  common  presentation  is  a  polypoid  intraluminal
ass  greater  than  1-cm  in  diameter  [11].  Finally,  gallbladder
denocarcinoma  can  present  as  a  symmetric  or  an  asymmet-
ic  gallbladder  wall  thickening  that  may  be  similar  to  that
bserved  in  chronic  cholecystitis  [11].  Clinically,  bile  duct
bstruction  is  present  in  25  %  of  patients  with  gallbladder
ancer  [12].
Primary  neuroendocrine  tumors  of  the  gallbladder  501
Figure 1. Fifty-ﬁve-year-old man presenting with non-speciﬁc abdominal pain and weight loss: a: MDCT of the abdomen in the axial
plane after intravenous administration of iodinated contrast material shows heterogeneous mass (arrow) in the fundus of the gallbladder in
association with large, heterogeneous lymphadenopathies (arrowheads) in the porta hepatis and retroportal space; b: MDCT of the abdomen
in the coronal plane shows a large, heterogeneous mass (arrows) in the fundus of the gallbladder. Intrahepatic metastasis (arrowhead) is
visible; c: photograph shows resected gross specimen of enlarged metastatic lymph nodes of porta hepatis; d: hematoxylin and eosin section
shows poorly differentiated neuroendocrine carcinoma made of monomorphic cells with small and round nuclei and eosinophilic cytoplasm
with serosal and liver invasion (magniﬁcation × 10); e: immunohistochemical staining shows a Ki-67 index (i.e., proliferation index) over
90 %.
Figure 2. Sixty-four-year-old woman presenting with abdominal pain and jaundice: a: ultrasonographic examination of the abdomen
reveals the presence of large, heterogeneous mass (arrows) measuring 75 × 67 mm that appears to originally develop from the gallbladder; b:
MDCT of the abdomen in the axial plane after intravenous administration of iodinated contrast material conﬁrms presence of a heterogeneous
mass (arrows) of the gallbladder measuring 82 × 65 mm in association with two hepatic metastases (white arrowheads) and lymphadenopathy
(curved arrow) in aortocaval space. Stone (black arrowhead) is visible in the gallbladder mass; c: at a different level of slice, MDCT of the
abdomen shows enlarged lymph nodes (white arrows) at the porta hepatis, encasing splenic vein (white arrowhead). Intrahepatic metastasis
Intrah
c
b
ewith peripheral hypoattenuating rim (black arrowhead) is visible. 
present.
In  our  two  patients,  MDCT  showed  a  large,  inﬁltrative
mass  with  associated  enlarged  lymph  nodes  at  the  porta
hepatis  in  both  patients  and  in  the  retrocaval  space  in
one  of  them.  MDCT  ﬁndings  were  suggestive  for  the  diag-
nosis  of  gallbladder  adenocarcinoma.  The  ﬁnal  diagnosis
was  made  after  histopathologic  analysis  similar  to  prior
t
t
cepatic bile duct dilatation (black arrows) in the left liver lobe is
ases  reported  in  the  literature  [2,3,9,10].  Of  interest,  in
oth  patients,  the  metastatic  lymph  nodes  were  abnormally
nlarged,  which  is  a  ﬁnding  that  has  not  been  reported  nei-
her  in  previous  cases  of  primary  neuroendocrine  tumors  of
he  gallbladder  nor  in  the  most  common  gallbladder  adeno-
arcinoma.
5c
d
v
a
e
l
a
o
n
p
n
o
b
b
o
w
o
a
t
w
t
n
b
t
s
a
s
r
M
t
l
t
v
m
d
t
i
f
D
T
c
R
[
[
[
[
[
[
[02  
Lymph  node  metastases  are  present  in  25  %  to  80  %  of
ases  of  gallbladder  adenocarcinomas  [13].  The  gallblad-
er  drains  to  the  superior  pancreaticoduodenal  lymph  nodes
ia  cystic,  pericholedochal  and  retroportal  lymph  nodes
nd  then  to  the  interaorticocaval  lymph  nodes  [1,8].  Direct
xtension  involves  segment  4  followed  by  segment  5  of  the
iver  and  can  be  responsible  for  capsular  retraction  of  the
djacent  liver  [14].
Therapeutic  options  for  primary  neuroendocrine  tumors
f  the  gallbladder  are  often  limited  due  to  the  advanced
ature  of  the  disease  at  diagnosis.  Surgical  resection  when
ossible  remains  the  best  option  for  cure  [15]. However,  the
eed  for  radical  resection  is  still  debated  [15,16].  Because
f  the  rarity  of  this  disease,  no  deﬁnite  treatment  has
een  clearly  deﬁned.  Adjuvant  chemotherapy  is  often  used
ut  there  is  no  well-deﬁned  protocol.  Effective  treatment
ptions  are  currently  limited  to  complete  surgical  resection
ith  negative  margins  [15].  Among  our  two  patients,  only
ne  was  amenable  to  extended  curative  resection  including
typical  partial  hepatectomy  with  chemotherapy  whereas
he  other  received  palliative  therapy  only  after  the  diagnosis
as  obtained  after  percutaneous  biopsy  [17].
Histopathologically,  primary  neuroendocrine  tumors  of
he  gallbladder  are  predominantly  poorly  differentiated
euroendocrine  tumors  [2,3,9].  The  deﬁnite  diagnosis  is
ased  on  immunohistochemical  expression  of  marker  pro-
eins.  In  our  two  patients,  immunohistochemical  analysis
howed  that  tumor  cells  were  negative  for  cytokeratin
nd  vimentin  and  positive  for  CD  56,  chromogranin  A  and
ynaptophysin,  thus  supporting  the  ﬁnal  diagnosis  of  neu-
oendocrine  tumor  [2,3,9].
In  conclusion,  we  have  reported  the  ultrasonograpic  and
DCT  ﬁndings  in  two  patients  with  primary  neuroendocrine
umors  of  the  gallbladder.  This  speciﬁc  tumor  presents  as
arge  heterogeneous  gallbladder  masses  that  are  similar  to
he  more  common  gallbladder  adenocarcinoma.  Our  obser-
ations  may  suggest  that  the  presence  of  markedly  enlarged
etastatic  lymph  nodes  might  be  a  discriminating  feature  to
ifferentiate  between  primary  neuroendocrine  tumor  and
he  more  common  adenocarcinoma  of  the  gallbladder  on
maging.  However,  this  assumption  should  be  validated  by
urther  comparative  case-control  studies.isclosure of interest
he  authors  declare  that  they  have  no  conﬂicts  of  interest
oncerning  this  article.
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